The role of matrix metalloproteinases in infant traumatic brain injury

Neurobiology of Disease

Volumn 25, Issue 3, 2007, Pages 526-535

  Sifringer, Marco ^a   Stefovska, Vanya ^a   Zentner, Ingo ^a   Hansen, Berglind ^a   Stepulak, Andrzej ^a,b   Knaute, Christiane ^a   Marzahn, Jenny ^a   Ikonomidou, Chrysanthy ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B; ILOMASTAT; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; BASAL GANGLION; BRAIN CORTEX; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; HISTOLOGY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING; WHITE MATTER; ZYMOGRAPHY;

AGE FACTORS; ANIMALS; APOPTOSIS; BRAIN; BRAIN INJURIES; DIPEPTIDES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IN SITU NICK-END LABELING; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NERVE DEGENERATION; PROTEASE INHIBITORS; RATS; RATS, WISTAR; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 33847176969     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.10.019     Document Type: Article

References (54)

1. Adelson P.D., and Kochanek P.M. Head injury in children. J. Child Neurol. 13 (1998) 2-15
2. Asahi M., Wang X., Mori T., Sumii T., Jung J.-C., Moskowitz A.A., Fini E., and Lo E.H. Effects of matrix metalloproteinase 9 gene knockout on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21 (2001) 7724-7732
3. Beer R., Franz G., Schopf M., Reindl M., Zelger B., Schmutzhard E., Poewe W., and Kampfl A. Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J. Cereb. Blood Flow Metab. 20 (2000) 669-677
4. Bethea J.R., Castro M., Keane R.W., Lee T.T., Dietrich D., and Yezierski R.P. Traumatic spinal cord injury induces nuclear factor kappa B activation. J. Neurosci. 18 (1998) 3251-3260
5. Bittigau P., Sifringer M., Pohl D., Stadthaus D., Ishimaru M., Shimizu H., Ikeda M., Lang D., Speer A., Olney J.W., and Ikonomidou C. Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann. Neurol. 45 (1999) 724-735
6. Carlos T.M., Clark R.S.B., Higgins D.F., Schiding J.K., and Kochanek P.M. Expression of endothelial adhesion molecules and recruitment of neutrophils after traumatic brain injury in rats. J. Leukocyte Biol. 61 (1997) 279-285
7. Chatzipantelli K., Alonso O.F., Kraydieh S., and Dietrich W.D. Importance of posttraumatic hypothermia and hyperthermia on the inflammatory response after fluid percussion brain injury: biochemical and immunocytochemical studies. J. Cereb. Blood Flow Metab. 20 (2000) 531-542
8. Chen Z.L., and Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91 (1997) 917-925
9. Cuzner M.L., and Opdenakker G. Plasminogen activators and matrix metalloproteinases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J. Neuroimmunol. 94 (1999) 1-14
10. Dixon C.E., Clifton G.L., Lighthall J.W., Yaghmai A.A., and Hayes R.L. A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 39 (1991) 253-262
11. Dobbing J., and Sands J. The brain growth spurt in various mammalian species. Early Hum. Dev. 3 (1979) 70-84
12. Felderhoff-Mueser U., Sifringer M., and Pesditschek S. Pathways leading to apoptotic neurodegeneration following trauma to the developing brain. Neurobiol. Dis. 11 (2002) 231-245
13. Goldstein M. Traumatic brain injury: a silent epidemic. Ann. Neurol. 27 (1990) 327
14. Gary D., and Mattson M.P. Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis. J. Neurochem. 76 (2001) 1485-1496
15. Gasche Y., Fujimura Y., Copin J., Kawase M., Masengale J., and Chan P.H. Early appearance of activated MMP-9 after focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19 (1999) 1020-1028
16. Gu Z., Kaul M., Yan B., Kridel S.J., Cui J., Strongin A., Smith J.W., Liddington R.C., and Lipton S.A. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297 (2002) 1186-1190
17. Gursoy-Ozdemir Y., Oiu J., Matsucka N., Bolay H., Bermpohl D., Jin H., Wang X., Rosenberg G.A., Lo E.H., and Moskowitz M.A. Cortical spreading depression activates and upregulates MMP-9. J. Clin Invest. 113 (2004) 1447-1455
18. Hagg T., Muir D., Engvall E., Varon S., and Manthorpe M. Laminin antigens in rat CNS: distribution and changes upon brain injury. Neuron 3 (1989) 721-732
19. Heo J.H., Lucero J., Abumiya T., Koizol J.A., Copeland B.R., and del Zoppo G.J. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19 (1999) 624-633
20. James H.E. Pediatric head injury: what is unique and different. Acta Neurochir., Suppl. (Wien) 73 (1999) 85-88
21. Kieseier B.C., Clements J.M., Pischel H.B., Wells G.M., Miller K., Gearing A.J., and Hartung H.P. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome. Ann. Neurol. 43 (1998) 427-434
22. Kieseier B.C., Kiefer R., Clements J.M., Miller K., Wells G.M., Schweitzer T., Gearing A.J., and Hartung H.P. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. Brain 121 (1998) 159-166
23. Koskiniemi M., Kyykka T., Nybo T., and Jarho L. Long-term outcome after severe brain injury in preschoolers is worse than expected. Arch. Pediatr. Adolesc. Med. 149 (1995) 249-254
24. Kraus J.F., Fife D., and Conroy C. Pediatric brain injuries: the nature, clinical course and early outcomes in a defined United States population. Pediatrics 79 (1987) 501-507
25. Lee S.R., and Lo E.H. Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J. Cereb. Blood Flow Metab. 24 (2004) 720-727
26. Lo E.H., Dalkara T., and Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev., Neurosci. 4 (2003) 399-415
27. Lukashev M.E., and Werb Z. ECM signalling: orchestrating cell behavior and misbehavior. Trends Cell. Biol. 8 (1998) 437-441
28. Martin-Villalba A., Herr I., Jeremias I., Hahne M., Brandt R., Vogel J., Schenkel J., Herdegen T., and Debatin K.M. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19 (1999) 3809-3817
29. Montaner J., Alvarez-Sabin J., Molina C.A., Angles A., Abilleira S., Arenillas J., Gonzalez M.A., and Monasterio J. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke 32 (2001) 1759-1766
30. Montaner J., Molina C.A., Monasterio J., Abilleira S., Arenillas J.F., Ribo M., Quintana M., and Alvarez-Sabin J. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107 (2003) 598-603
31. Morita-Fijimura Y., Fujimura M., Gasche Y., Copin J., and Chan P.H. Overexpression of copper and zinc superoxide dismutase in transgenic mice prevents the induction and activation of matrix metalloproteinases after cold injury induced brain trauma. J. Cereb. Blood Flow Metab. 20 (1999) 130-138
32. Murtomaki S., Trekner E., Wright J., Saksela O., and Liesi P. Increased proteolytic activity of the granule neurons may contribute to neuronal death in the weaver mouse cerebellum. Dev. Biol. 168 (1995) 635-648
33. Nagase H., and Woessner J.F. Matrix metalloproteinases: a minireview. J. Biol. Chem. 274 (1999) 21491-21494
34. Noble L.J., Donovan F., Igarashi T., Goussev S., and Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J. Neurosci. 22 (2002) 5726-5735
35. Pagenstecher A., Stalder A.K., Kincaid C.L., Shapiro S.D., and Campbell I.L. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in mouse CNS in normal and inflammatory states. Am. J. Pathol. 152 (1998) 729-741
36. Pohl D., Bittigau P., Ishimaru M.J., Stadthaus D., Voeckler J., Huebner C., Olney J.W., Turski L., and Ikonomidou C. NMDA antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2508-2513
37. Powell W.C., Fingleton B., Wilson C.L., Boothby M., and Matrisian L.M. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr. Biol. 9 (1999) 1441-1447
38. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., and Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats. Stroke 29 (1998) 1020-1030
39. Rosenberg G.A., Navratil M., Barone F., and Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J. Cereb. Blood Flow Metab. 16 (1996) 360-366
40. Scherbel U., Raghupathi R., Nakamura M., Saatman K.E., Trojanowki J.Q., Neugebauer E., Marino M.W., and McIntosh T.K. Differential acute and chronic responses of tumor necrosis factor deficient mice to experimental brain injury. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 8721-8726
41. Schmued L., Albertson C., and Slikker W. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751 (1997) 37-46
42. Shigemori Y., Katayama Y., Mori T., Maeda T., and Kawatama T. Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats. Acta Neurochir., Suppl. 96 (2006) 130-133
43. Sosin D.M., Sniezek J.E., and Waxweiler R.J. Trends in death associated with traumatic brain injury, 1979 through 1992. Success and failure. JAMA 273 (1995) 1778-1780
44. Sullivan P.G., Bruce-Keller A.J., Rabchevsky A.G., Christakos S., Clair D.K., Mattson M.P., and Scheff S.W. Exacerbation of damage and altered NFkB activation in mice lacking TNF receptors after traumatic brain injury. J. Neurosci. 19 (1999) 6248-6256
45. Thurman D.J., Alverson C., Dunn K.A., Guerrero J., and Sniezek J.E. Traumatic brain injury in the United States: a public health perspective. J. Head Trauma Rehabil. 14 (1999) 602-615
46. Tsirka S.E., Rogove A.D., Bugge T.H., Degen J.L., and Strickland S. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J. Neurosci. 17 (1997) 543-552
47. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., Shapiro S.D., Senior R.M., and Werb Z. MMP-9 is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93 (1998) 411-422
48. Wang X., Jung J., Asahi M., Chwang W., Russo L., Moskowitz M.A., Dixon C.E., Fini M.E., and Lo E.H. Effects of matrix metalloproteinase-9 knock-out on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20 (2000) 7037-7042
49. Wang X., Lee S.R., Arai K., Lee S.R., Tsuji K., Rebeck G.W., and Lo E.H. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat. Med. 9 (2003) 1313-1317
50. Wells J.E.A., Rice T.K., Nuttall R.K., Edwards D.R., Zekki H., Rivest S., and Yong V.W. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J. Neurosci. 23 (2003) 10107-10115
51. West M.J., and Gundersen H.J. Unbiased stereological estimation of the number of neurons in the human hippocampus. J. Comp. Neurol. 296 (1990) 1-22
52. Yong V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Neurosci. 6 (2005) 931-944
53. Yong V.W., Krekoski C.A., Forsyth P.A., Bell R., and Edwards D.R. Matrix metalloproteinases and disease of the CNS. Trends Neurosci. 21 (1998) 75-80
54. Zhao B.Q., Wang S., Kim H.Y., Storrie H., Rosen B.R., Mooney D.J., Wang X., and Lo E.H. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12 (2006) 441-445